Sign In
Get Clay Free →

Suggestions

    Nathaniel Wang

    Founder - Executive - Immunologist

    Nathaniel Wang is the Chief Executive Officer and Co-Founder of Replicate Bioscience, Inc., a company focused on advancing RNA therapeutics through innovative self-replicating RNA (srRNA) technology. With over 15 years of experience in immunology and drug development, he has established himself as a pioneer in synthetic RNA technologies, particularly in their application for immunotherapies targeting oncology and infectious diseases.12

    Professional Background

    • Current Role: Wang has been with Replicate Bioscience since February 2020, where he leads the development of srRNA platforms aimed at improving treatment efficacy across various therapeutic areas.12
    • Previous Experience:
      • Synthetic Genomics: He served as the Head of the RNA Medicines Business Unit, where he developed a self-replicating RNA asset that was sold to Janssen Pharmaceuticals in 2019.12
      • Janssen Pharmaceuticals: In his role as a Scientific Integrator, he established frameworks for drug discovery and development across multiple therapeutic areas.12
      • Research Contributions: Wang has held various positions focusing on immunology and drug development, contributing to significant advancements in RNA medicines and therapeutics.1

    Education

    Wang holds a Ph.D. in Immunology from The Scripps Research Institute and a B.A. in Molecular and Cellular Biology from the University of California, Berkeley. His academic background has provided a strong foundation for his research and leadership in biotechnology.12

    Contributions and Innovations

    Nathaniel Wang is recognized for his contributions to the field of synthetic biology, holding multiple patents related to RNA-based platforms for vaccines and therapeutics. His work emphasizes enhancing the safety and efficacy of RNA treatments, aiming to expand their use in clinical settings.13

    In summary, Nathaniel Wang's leadership at Replicate Bioscience reflects his commitment to pioneering advancements in RNA therapeutics, drawing on his extensive experience in both biotech and pharmaceutical industries.

    Highlights

    What's next for advanced therapies? - Cytiva
    Jan 11 · informaconnect.com
    Nathaniel Wang - Replicate Bioscience | RNA Leaders USA Speaker

    Related Questions

    What are the key achievements of Nathaniel Wang at Replicate Bioscience, Inc?
    How did Nathaniel Wang's experience at Synthetic Genomics influence his work at Replicate Bioscience, Inc?
    What are the main challenges Nathaniel Wang has faced in developing synthetic, self-replicating RNA technologies?
    How does Nathaniel Wang's background in immunology contribute to his leadership at Replicate Bioscience, Inc?
    What future projects is Nathaniel Wang planning at Replicate Bioscience, Inc?
    Nathaniel Wang
    Nathaniel Wang, photo 1
    Nathaniel Wang, photo 2
    Add to my network

    Location

    San Diego County, California, United States